I-MAK's Tahir Amin presses US Congress on effect of patents on drug prices
Tahir Amin, CEO of the IP advocacy group Initiative for Medicines, Access, and Knowledge, is urging lawmakers to examine how patent practices such as evergreening and thickets drive up drug costs....To view the full article, register now.
Already a subscriber? Click here to view full article